Top News

The Latest News and Select Stories About Intrance Medical Systems

January 4, 2022
Intrance Medical Systems Completes $17 Million Series A Financing and Appoints Ed Schutter to Board of Directors
November 2, 2021
Leading US-Swedish entrepreneur Rutger Arnhult invests in Intrance Medical Inc’s advanced stage Parkinson’s disease treatment system
September 20, 2021
Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson’s Disease
August 17, 2021
Intrance Medical Systems Names Krai Chatamra, Ph.D., Vice President of Clinical Development
May 13, 2021
Intrance Medical Systems Establishes U.S. Operations and Names Patrick Shea Chief Executive Officer
October 2, 2020
STADA expands specialty footprint through acquisition of innovative therapy for treating advanced Parkinson’s disease
September 17, 2020
Lobsor Pharmaceuticals receives approval for Lecigon in Germany, the Netherlands, Belgium, Austria, Slovenia and Romania
October 30, 2019
Japanese patent granted for Lobsor Pharmaceuticals’ new therapeutic system Lecigon®
October 1, 2019
Lobsor receives approval for Lecigon® in Denmark, Finland and Norway
November 2, 2015
Primary endpoint achieved in pivotal EU study

In The News

October 2021
Parkinson's News Today
October 2019
The Pharma Letter
October 2019
Nordic Life Science